ArticleOncology letters2023

Correlation between immune-related adverse events and treatment efficacy of anti-PD1 immunotherapy in patients with esophageal squamous cell carcinoma.

Ruijie Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.